Saturday, June 20, 2026

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 116 of 1,261
  1. US 11993658

    Anti-BCMA antibodies and treatment methods

    Sutro Biopharma, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  2. US 11993644

    Antigen binding molecules targeting SARS-CoV-2

    Generate Biomedicines, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  3. US 11993603

    Preparation for 6-amino-1H-pyrazolo[3,4-d]pyrimidine-based JAK kinase inhibitor and application thereof

    CHINA PHARMACEUTICAL UNIVERSITY · Granted May 28, 2024 · Expires May 23, 2044

    granted
  4. US 11993580

    Methods of treating neurological disorders

    Neumora Therapeutics, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  5. US 11993638

    GM-CSF mimetics and methods of making and using same

    The Regents of the University of Colorado, a Body Corporate · Granted May 28, 2024 · Expires May 23, 2044

    granted
  6. US 11993600

    Saturated spirocyclics as antiviral agents

    Enanta Pharmaceuticals, Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  7. US 11992530

    Therapeutic uses for sodium thiosulfate and formulations

    Fennec Pharn ceuticals Inc. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  8. US 11992531

    C3-carbon linked glutarimide degronimers for target protein degradation

    C4 THERAPEUTICS, INC. · Granted May 28, 2024 · Expires May 23, 2044

    granted
  9. US 11993569

    3-amino-4-halocyclopentene carboxylic acids as inactivators of aminotransferases

    Northwestern University · Granted May 28, 2024 · Expires May 23, 2044

    granted
  10. US 2024166750

    GLYCOENGINEERED Fc VARIANT POLYPEPTIDES WITH ENHANCED EFFECTOR FUNCTION

    ABLYNX NV [BE] · Granted May 23, 2024 · Expires May 18, 2044

    granted
  11. AU 2022263543

    Pharmaceutical compositions comprising sorbitan esters

    ALKERMES PHARMA IRELAND LTD [IE] · Granted May 23, 2024 · Expires May 18, 2044

    granted
  12. US 11986511

    Use of a VEGF antagonist to treat angiogenic eye disorders

    REGENERON PHARMACEUTICALS, INC. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  13. US 11986471

    Compounds and methods of use

    Tango Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  14. US 11986534

    Treatment of anthrax with pegylated capsule-degrading enzyme

    The Government of the United States of America, as represented by the Secretary of the Navy · Granted May 21, 2024 · Expires May 16, 2044

    granted
  15. US 11986537

    Muscle targeting complexes and uses thereof for treating dystrophinopathies

    Dyne Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  16. US 11987586

    Pyrrolo[1,2-c]imidazole derivatives as orexin type 2 receptor agonists

    Takeda Pharmaceutical Company Limited · Granted May 21, 2024 · Expires May 16, 2044

    granted
  17. US 11987548

    Methods of making bempedoic acid and compositions of the same

    Esperion Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  18. US 11987628

    Methods and compositions for modulating CAR-T activity

    Sana Biotechnology, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  19. US 11987821

    Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy

    Entrada Therapeutics, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  20. US 11987792

    Compositions and methods for inhibiting expression of the LECT2 gene

    Alnylam Pharmaceuticals, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  21. US 11987590

    Compounds that participate in cooperative binding and uses thereof

    Revolution Medicines, Inc. · Granted May 21, 2024 · Expires May 16, 2044

    granted
  22. US 11986561

    Wound dressings and applications thereof

    The Board of Regents of the University of Texas System · Granted May 21, 2024 · Expires May 16, 2044

    granted
  23. US 11986442

    Inhibition of respiratory complex III by ligands that interact with a regulatory switch

    The Regents of the University of California · Granted May 21, 2024 · Expires May 16, 2044

    granted
  24. US 11987600

    Contraceptive use of triterpenoids

    The Regents of the University of California · Granted May 21, 2024 · Expires May 16, 2044

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.